3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
23
Lymphoma, Non-Hodgkin
22
Lymphoma, Large B-Cell, Diffuse
16
Hodgkin Disease
16
Lymphoma, Mantle-Cell
13
Lymphoma, Follicular
13
Burkitt Lymphoma
9
Multiple Myeloma
7
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, B-Cell
6
Glioblastoma
6
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, T-Cell
4
Gliosarcoma
4
Glioma
4
Recurrence
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Leukemia, Myeloid, Acute
3
Congenital Abnormalities
3
Astrocytoma
3
Waldenstrom Macroglobulinemia
2
Primary Myelofibrosis
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Myelodysplastic Syndromes
2
Interventions
Gemcitabine
153
Fluorouracil
45
Capecitabine
45
130-nm albumin-bound paclitaxel
43
Oxaliplatin
42
Albumin-Bound Paclitaxel
39
Leucovorin
31
Erlotinib Hydrochloride
30
pembrolizumab
23
Radiotherapy
22
Irinotecan
22
Radiosurgery
20
Bevacizumab
19
Docetaxel
17
Cyclophosphamide
17
Taxes
13
Cisplatin
13
Cetuximab
13
folfirinox
12
Nivolumab
11
Surgical Procedures, Operative
7
Paclitaxel
7
Ipilimumab
7
dehydroftorafur
6
Standard of Care
6
Radiation
6
Magnetic Resonance Spectroscopy
6
spartalizumab
5
ruxolitinib
5
durvalumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pancreatic Neoplasms
×
Carmustine
×
Clear all
No trials found.